Salvage Use of Citalopram for Treatment of Fluoxetine-Resistant Premature Ejaculation in Recently Married Men A Prospective Clinical Trial

Dadfar, Mohammad Reza; Baghinia, Mahmood Reza
January 2010
Urology Journal;Nov2010, Vol. 7 Issue 1, p40
Academic Journal
Introduction: A wide variety of therapeutic modalities have been tried for treatment of premature ejaculation. Selective serotonin reuptake inhibitors are from the latest and most effective medical agents. Among these drugs, fluoxetine hydrochloride has been used for some years in our institutions with considerable drug untoward effects and significant failure rates. We tried to salvage treatment process by using citalopram in fluoxetine-resistant patients. Materials and Methods: In a prospective clinical trial, we used citalopram hydrobromide as a salvage agent in 16 newly married men with premature ejaculation who experienced a history of unsuccessful treatment with fluoxetine hydrochloride. Intravaginal ejaculation latency time (IVELT) was recorded by a stopwatch before and after the treatment, and a 5-stage visual scale was designed and used to compare patients' sexual satisfaction levels during the 1-month treatment period. Results: The IVELT and sexual satisfaction levels both significantly improved after citalopram prescription. The mean measured IVELT was 0.388 ± 0.212 minutes before the treatment, which increased to 4.313 ± 2.886 minutes after the treatment. The reported drug untoward effects were mild. Citalopram was ineffective only in 1 patient, which was discontinued after 4 weeks. Conclusion: Our study showed that citalopram is effective and safe in the treatment of premature ejaculation in newly married men after failed treatment with fluoxetine.


Related Articles

  • Dapoxetine. Feret, Brett // Formulary;Jul2005, Vol. 40 Issue 7, p227 

    Dapoxetine (Alza/Ortho-McNeil) is a novel oral medication undergoing FDA review for premature ejaculation, one of the most common disorders of sexual dysfunction in men. Dapoxetine is a fast-acting inhibitor of the serotonin reuptake transporter. It has a short half-life and is structurally...

  • Dapoxetine: In Premature Ejaculation. Hoy, Sheridan M.; Scott, Lesley J. // Drugs;2010, Vol. 70 Issue 11, p1433 

    Dapoxetine, a selective serotonin reuptake inhibitor, is the first oral pharmacological agent indicated for the treatment of men aged 18-64 years with premature ejaculation. In four randomized, double-blind, placebocontrolled, multicentre studies of 12-24 weeks' duration, oral dapoxetine 30 or...

  • Efficacy of selective serotonin reuptake inhibitor (SSRI) in patient with premature ejaculation. Rezakhaniha, Bijan; Sirosbakht, Soheila // Iranian Journal of Reproductive Medicine;Spring2010, Vol. 8 Issue 2, p55 

    Background: Premature ejaculation (PE) is the most common sexual dysfunction compliant in about 35-40% of men younger than 40 years; therefore a study for survey and diagnosis of this disorder is very important. Objective: In this study, the efficacy of 2 drugs (fluoxetine and citalopram) for...

  • Eiaculazione Precoce: compliance, effetti collaterali e benefici della farmacoterapia con Dapoxetina e un tradizionale inibitore del reuptake della serotonina (Citalopram) in 59 pazienti. Pavone, Carlo; Gesolfo, Cristina Scalici; Abbadessa, Daniela; Scaduto, Giovanna; Caruana, Giovanni; Siracusa, Giuseppe; Gambino, Giuseppa; Marguglio, Vincenzo // Urologia;2013, Vol. 80 Issue 1, p56 

    INTRODUCTION: Premature ejaculation (PE) is a sexual dysfunction with high prevalence. According to some reports, it is present in about 20-30% of the male population. Since 2009 PE has been treated with a novel inhibitor of serotonin re-uptake, Dapoxetine, which has been reported to be...

  • Adverse Effects on Semen from SSRI Treatment of Premature Ejaculation. Kuritzky, Louis // Internal Medicine Alert;1/15/2012 Supplement, p7 

    The article discusses a study which found that sustained use of selective serotonin reuptake inhibitors (SSRI) for the treatment of premature ejaculation has adverse effects on semen.

  • Adverse Effects on Semen from SSRI Treatment of Premature Ejaculation. Kuritzky, Louis // Infectious Disease Alert;Feb2012 Clinical Briefs, p3 

    The article discusses research by H. Koyuncu and colleagues, published in a 2011 issue of "International Journal of Impotence Research" on the effects of using selective serotonin reuptake inhibitors (SSRIs) to treat premature ejaculation.

  • Men with premature ejaculation respond well to SSRIs. Guttman, Cheryl // Urology Times;Apr2003, Vol. 31 Issue 4, p43 

    Discusses a study showing that men with acquired and lifelong premature ejaculation respond equally well in the short term to various selective serotonin re-uptake inhibitor (SSRI) drugs. Differences in long-term therapeutic responses; Likelihood for achieving restoration of ejaculatory control...

  • A Benefit-Risk Assessment of Dapoxetine in the Treatment of Premature Ejaculation. Hutchinson, Kate; Cruickshank, Kelly; Wylie, Kevan // Drug Safety;2012, Vol. 35 Issue 5, p359 

    Premature ejaculation (PE) is considered to be the most common sexual problem affecting men, despite the likelihood that it is under-diagnosed. It is a complex condition with many physical and psychological components, making management complicated. It is important to develop treatments for PE...

  • What's the best drug treatment for premature ejaculation? Mercado, Michael G.; Kimmer, Sandra L.; Holman, John R.; Wanserski, Gerri // Journal of Family Practice;Mar2008, Vol. 57 Issue 3, p192 

    The article presents studies in male rats which examine the best drug treatment for premature ejaculation, which is considered as the most common male sexual dysfunction. These studies reveal the role of serotonin with various 5-Hydroxytryptamine receptor (5-HT) subtypes in the ejaculatory...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics